The latest price target for Clover Health Investments (NASDAQ:CLOV) was reported by Citigroup on August 11, 2023. The analyst firm set a price target for $1.50 expecting CLOV to fall to within 12 months (a possible -48.45% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Clover Health Investments (NASDAQ:CLOV) was provided by Citigroup, and Clover Health Investments maintained their neutral rating.

The last upgrade for Clover Health Investments Corp happened on February 2, 2022 when Cowen & Co. raised their price target to $3. Cowen & Co. previously had an underperform for Clover Health Investments Corp.

The last downgrade for Clover Health Investments Corp happened on January 7, 2022 when Credit Suisse changed their price target from $9 to $3.5 for Clover Health Investments Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clover Health Investments, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clover Health Investments was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

While ratings are subjective and will change, the latest Clover Health Investments (CLOV) rating was a maintained with a price target of $1.00 to $1.50. The current price Clover Health Investments (CLOV) is trading at is $2.91, which is out of the analyst’s predicted range.